Loading…
Safety of photodynamic therapy involving optic nerve head
We present a case of large peripapillary polypoidal choroidal vasculopathy treated with standard-fluence photodynamic therapy (PDT) as other treatment options were unsuccessful or not justified. Due to large lesion size, treatment spot included part of optic disc also. PDT resulted in regression of...
Saved in:
Published in: | Indian journal of ophthalmology 2020-03, Vol.68 (3), p.530-533 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c581n-9078966f99a0d158b2ab39f5aa4b4f50dbde1a073761da564949fbd2e2d049ef3 |
container_end_page | 533 |
container_issue | 3 |
container_start_page | 530 |
container_title | Indian journal of ophthalmology |
container_volume | 68 |
creator | Manayath, George Verghese, Shishir Jain, Nidhee Ranjan, Ratnesh Narendran, Venkatapathy |
description | We present a case of large peripapillary polypoidal choroidal vasculopathy treated with standard-fluence photodynamic therapy (PDT) as other treatment options were unsuccessful or not justified. Due to large lesion size, treatment spot included part of optic disc also. PDT resulted in regression of polyp and visual improvement (from 20/300 to 20/20) without any collateral damage to optic nerve as evidenced by visual-field test and visual-evoked potential with a follow-up till 2 years. This case highlights the role of PDT as a safe alternative for treatment of large peripapillary lesion, even though the treatment spot encompasses part of the optic nerve head. |
doi_str_mv | 10.4103/ijo.IJO_1081_19 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0d781fb8c7714e089f5857cd89c3c3cb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A614062411</galeid><doaj_id>oai_doaj_org_article_0d781fb8c7714e089f5857cd89c3c3cb</doaj_id><sourcerecordid>A614062411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581n-9078966f99a0d158b2ab39f5aa4b4f50dbde1a073761da564949fbd2e2d049ef3</originalsourceid><addsrcrecordid>eNp1ksFv0zAUxi0EYmVw5oYicU73HDuxfUGapgGFSTsAZ8uJ7TZdagcnbdX_ngcpY5WKfLD0_Hufv2d_hLylMOcU2FW7jvPFl3tNQVJN1TMyo0rJnFVSPSczYEBzLpi8IK-GYQ3ABFXyJblgBZQCimpG1Dfj3XjIos_6VRyjPQSzaZtsXLlk-kPWhl3sdm1YZrEfsR5c2rls5Yx9TV540w3uzXG_JD8-3n6_-Zzf3X9a3Fzf5U0pacgVCKmqyitlwNJS1oWpmfKlMbzmvgRbW0cNCCYqak1ZccWVr23hCgtcOc8uyWLStdGsdZ_ajUkHHU2r_xRiWmqT0FrnNFghqa9lIwTlDiReI0vRWKkahqtGrQ-TVr-tN842LozJdCeipyehXell3GkBnKF5FHh_FEjx59YNo17HbQo4vy4Ymsc5KP9HLQ26aoOPKNZs2qHR1xXlUBWcUqTyM9TS4RObLgbnWyyf8PMzPC7r8MfONlxNDU2Kw5CcfxyUgv4dH43x0U_igx3vnr7PI_83Lwh8nYB97EaXhoduu3dJI_sQ4v5_urpkoKeg6YgujkFjvwB-Gdp3</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2356407314</pqid></control><display><type>article</type><title>Safety of photodynamic therapy involving optic nerve head</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Manayath, George ; Verghese, Shishir ; Jain, Nidhee ; Ranjan, Ratnesh ; Narendran, Venkatapathy</creator><creatorcontrib>Manayath, George ; Verghese, Shishir ; Jain, Nidhee ; Ranjan, Ratnesh ; Narendran, Venkatapathy</creatorcontrib><description>We present a case of large peripapillary polypoidal choroidal vasculopathy treated with standard-fluence photodynamic therapy (PDT) as other treatment options were unsuccessful or not justified. Due to large lesion size, treatment spot included part of optic disc also. PDT resulted in regression of polyp and visual improvement (from 20/300 to 20/20) without any collateral damage to optic nerve as evidenced by visual-field test and visual-evoked potential with a follow-up till 2 years. This case highlights the role of PDT as a safe alternative for treatment of large peripapillary lesion, even though the treatment spot encompasses part of the optic nerve head.</description><identifier>ISSN: 0301-4738</identifier><identifier>EISSN: 1998-3689</identifier><identifier>DOI: 10.4103/ijo.IJO_1081_19</identifier><identifier>PMID: 32057026</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Aflibercept ; Case Reports ; Choroid - blood supply ; Civilian casualties ; Female ; Fluorescein Angiography - methods ; Fundus Oculi ; Humans ; Lasers ; Medical imaging ; Middle Aged ; Optic Disk - diagnostic imaging ; Optic nerve ; optic nerve head ; Patients ; Photochemotherapy ; Photochemotherapy - methods ; Photodynamic therapy ; Photosensitizing Agents - therapeutic use ; polypoidal choroidal vasculopathy ; Polyps - diagnosis ; Polyps - drug therapy ; Ranibizumab ; Tomography, Optical Coherence ; Vascular diseases ; Verteporfin ; Verteporfin - therapeutic use ; Visual Acuity ; Visual evoked potentials</subject><ispartof>Indian journal of ophthalmology, 2020-03, Vol.68 (3), p.530-533</ispartof><rights>COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.</rights><rights>2020. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2020 Indian Journal of Ophthalmology 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c581n-9078966f99a0d158b2ab39f5aa4b4f50dbde1a073761da564949fbd2e2d049ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043158/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2356407314?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,44589,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32057026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manayath, George</creatorcontrib><creatorcontrib>Verghese, Shishir</creatorcontrib><creatorcontrib>Jain, Nidhee</creatorcontrib><creatorcontrib>Ranjan, Ratnesh</creatorcontrib><creatorcontrib>Narendran, Venkatapathy</creatorcontrib><title>Safety of photodynamic therapy involving optic nerve head</title><title>Indian journal of ophthalmology</title><addtitle>Indian J Ophthalmol</addtitle><description>We present a case of large peripapillary polypoidal choroidal vasculopathy treated with standard-fluence photodynamic therapy (PDT) as other treatment options were unsuccessful or not justified. Due to large lesion size, treatment spot included part of optic disc also. PDT resulted in regression of polyp and visual improvement (from 20/300 to 20/20) without any collateral damage to optic nerve as evidenced by visual-field test and visual-evoked potential with a follow-up till 2 years. This case highlights the role of PDT as a safe alternative for treatment of large peripapillary lesion, even though the treatment spot encompasses part of the optic nerve head.</description><subject>Aflibercept</subject><subject>Case Reports</subject><subject>Choroid - blood supply</subject><subject>Civilian casualties</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Fundus Oculi</subject><subject>Humans</subject><subject>Lasers</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Optic Disk - diagnostic imaging</subject><subject>Optic nerve</subject><subject>optic nerve head</subject><subject>Patients</subject><subject>Photochemotherapy</subject><subject>Photochemotherapy - methods</subject><subject>Photodynamic therapy</subject><subject>Photosensitizing Agents - therapeutic use</subject><subject>polypoidal choroidal vasculopathy</subject><subject>Polyps - diagnosis</subject><subject>Polyps - drug therapy</subject><subject>Ranibizumab</subject><subject>Tomography, Optical Coherence</subject><subject>Vascular diseases</subject><subject>Verteporfin</subject><subject>Verteporfin - therapeutic use</subject><subject>Visual Acuity</subject><subject>Visual evoked potentials</subject><issn>0301-4738</issn><issn>1998-3689</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ksFv0zAUxi0EYmVw5oYicU73HDuxfUGapgGFSTsAZ8uJ7TZdagcnbdX_ngcpY5WKfLD0_Hufv2d_hLylMOcU2FW7jvPFl3tNQVJN1TMyo0rJnFVSPSczYEBzLpi8IK-GYQ3ABFXyJblgBZQCimpG1Dfj3XjIos_6VRyjPQSzaZtsXLlk-kPWhl3sdm1YZrEfsR5c2rls5Yx9TV540w3uzXG_JD8-3n6_-Zzf3X9a3Fzf5U0pacgVCKmqyitlwNJS1oWpmfKlMbzmvgRbW0cNCCYqak1ZccWVr23hCgtcOc8uyWLStdGsdZ_ajUkHHU2r_xRiWmqT0FrnNFghqa9lIwTlDiReI0vRWKkahqtGrQ-TVr-tN842LozJdCeipyehXell3GkBnKF5FHh_FEjx59YNo17HbQo4vy4Ymsc5KP9HLQ26aoOPKNZs2qHR1xXlUBWcUqTyM9TS4RObLgbnWyyf8PMzPC7r8MfONlxNDU2Kw5CcfxyUgv4dH43x0U_igx3vnr7PI_83Lwh8nYB97EaXhoduu3dJI_sQ4v5_urpkoKeg6YgujkFjvwB-Gdp3</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Manayath, George</creator><creator>Verghese, Shishir</creator><creator>Jain, Nidhee</creator><creator>Ranjan, Ratnesh</creator><creator>Narendran, Venkatapathy</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>Wolters Kluwer - Medknow</general><general>Wolters Kluwer Medknow Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200301</creationdate><title>Safety of photodynamic therapy involving optic nerve head</title><author>Manayath, George ; Verghese, Shishir ; Jain, Nidhee ; Ranjan, Ratnesh ; Narendran, Venkatapathy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581n-9078966f99a0d158b2ab39f5aa4b4f50dbde1a073761da564949fbd2e2d049ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aflibercept</topic><topic>Case Reports</topic><topic>Choroid - blood supply</topic><topic>Civilian casualties</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Fundus Oculi</topic><topic>Humans</topic><topic>Lasers</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Optic Disk - diagnostic imaging</topic><topic>Optic nerve</topic><topic>optic nerve head</topic><topic>Patients</topic><topic>Photochemotherapy</topic><topic>Photochemotherapy - methods</topic><topic>Photodynamic therapy</topic><topic>Photosensitizing Agents - therapeutic use</topic><topic>polypoidal choroidal vasculopathy</topic><topic>Polyps - diagnosis</topic><topic>Polyps - drug therapy</topic><topic>Ranibizumab</topic><topic>Tomography, Optical Coherence</topic><topic>Vascular diseases</topic><topic>Verteporfin</topic><topic>Verteporfin - therapeutic use</topic><topic>Visual Acuity</topic><topic>Visual evoked potentials</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manayath, George</creatorcontrib><creatorcontrib>Verghese, Shishir</creatorcontrib><creatorcontrib>Jain, Nidhee</creatorcontrib><creatorcontrib>Ranjan, Ratnesh</creatorcontrib><creatorcontrib>Narendran, Venkatapathy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Indian journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manayath, George</au><au>Verghese, Shishir</au><au>Jain, Nidhee</au><au>Ranjan, Ratnesh</au><au>Narendran, Venkatapathy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety of photodynamic therapy involving optic nerve head</atitle><jtitle>Indian journal of ophthalmology</jtitle><addtitle>Indian J Ophthalmol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>68</volume><issue>3</issue><spage>530</spage><epage>533</epage><pages>530-533</pages><issn>0301-4738</issn><eissn>1998-3689</eissn><abstract>We present a case of large peripapillary polypoidal choroidal vasculopathy treated with standard-fluence photodynamic therapy (PDT) as other treatment options were unsuccessful or not justified. Due to large lesion size, treatment spot included part of optic disc also. PDT resulted in regression of polyp and visual improvement (from 20/300 to 20/20) without any collateral damage to optic nerve as evidenced by visual-field test and visual-evoked potential with a follow-up till 2 years. This case highlights the role of PDT as a safe alternative for treatment of large peripapillary lesion, even though the treatment spot encompasses part of the optic nerve head.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>32057026</pmid><doi>10.4103/ijo.IJO_1081_19</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-4738 |
ispartof | Indian journal of ophthalmology, 2020-03, Vol.68 (3), p.530-533 |
issn | 0301-4738 1998-3689 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0d781fb8c7714e089f5857cd89c3c3cb |
source | Open Access: PubMed Central; Publicly Available Content Database |
subjects | Aflibercept Case Reports Choroid - blood supply Civilian casualties Female Fluorescein Angiography - methods Fundus Oculi Humans Lasers Medical imaging Middle Aged Optic Disk - diagnostic imaging Optic nerve optic nerve head Patients Photochemotherapy Photochemotherapy - methods Photodynamic therapy Photosensitizing Agents - therapeutic use polypoidal choroidal vasculopathy Polyps - diagnosis Polyps - drug therapy Ranibizumab Tomography, Optical Coherence Vascular diseases Verteporfin Verteporfin - therapeutic use Visual Acuity Visual evoked potentials |
title | Safety of photodynamic therapy involving optic nerve head |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T20%3A39%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20of%20photodynamic%20therapy%20involving%20optic%20nerve%20head&rft.jtitle=Indian%20journal%20of%20ophthalmology&rft.au=Manayath,%20George&rft.date=2020-03-01&rft.volume=68&rft.issue=3&rft.spage=530&rft.epage=533&rft.pages=530-533&rft.issn=0301-4738&rft.eissn=1998-3689&rft_id=info:doi/10.4103/ijo.IJO_1081_19&rft_dat=%3Cgale_doaj_%3EA614062411%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c581n-9078966f99a0d158b2ab39f5aa4b4f50dbde1a073761da564949fbd2e2d049ef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2356407314&rft_id=info:pmid/32057026&rft_galeid=A614062411&rfr_iscdi=true |